This course has expired. View available courses.
Cardiovascular
Stroke Prevention in Atrial Fibrillation: Supporting Effective DOAC Therapy – Canadian Council On Continuing Education In Pharmacy (CCCEP)
DURATION
PROFESSION
# OF CREDITS
1
ACCREDITATION
EXPIRY DATE
2018-06-01
Learning objectives
After successful completion of the program, the participant will be able to:
- Make recommendations that support the safe, effective, and appropriate use of DOAC therapy in patients with NVAF based on patient characteristics.
- Describe the role of the pharmacist in stroke prevention for patients who have NVAF and are receiving DOAC therapy.
- Counsel patients on the safe and appropriate use of DOAC medications to support best outcomes including adherence.
DOAC = direct oral anticoagulant
NVAF = non-valvular atrial fibrillation
Cost of course:
Free